161 related articles for article (PubMed ID: 30953357)
1. AIM2 promotes non-small-cell lung cancer cell growth through inflammasome-dependent pathway.
Zhang M; Jin C; Yang Y; Wang K; Zhou Y; Zhou Y; Wang R; Li T; Hu R
J Cell Physiol; 2019 Nov; 234(11):20161-20173. PubMed ID: 30953357
[TBL] [Abstract][Full Text] [Related]
2. Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment.
Yu Q; Zhang M; Ying Q; Xie X; Yue S; Tong B; Wei Q; Bai Z; Ma L
Cell Death Dis; 2019 Mar; 10(3):218. PubMed ID: 30833546
[TBL] [Abstract][Full Text] [Related]
3. AIM2 promotes the development of non-small cell lung cancer by modulating mitochondrial dynamics.
Qi M; Dai D; Liu J; Li Z; Liang P; Wang Y; Cheng L; Zhan Y; An Z; Song Y; Yang Y; Yan X; Xiao H; Shao H
Oncogene; 2020 Mar; 39(13):2707-2723. PubMed ID: 32005973
[TBL] [Abstract][Full Text] [Related]
4. Cytosolic DNA sensor AIM2 promotes KRAS-driven lung cancer independent of inflammasomes.
Alanazi M; Weng T; McLeod L; Gearing LJ; Smith JA; Kumar B; Saad MI; Jenkins BJ
Cancer Sci; 2024 Jun; 115(6):1834-1850. PubMed ID: 38594840
[TBL] [Abstract][Full Text] [Related]
5. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
6. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
Liu M; Zhou K; Huang Y; Cao Y
J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212
[TBL] [Abstract][Full Text] [Related]
7. Absent in melanoma 2 enhances anti-tumour effects of CAIX promotor controlled conditionally replicative adenovirus in renal cancer.
Chai D; Qiu D; Zhang Z; Yuchen Shi S; Wang G; Fang L; Li H; Li H; Tian H; Zheng J
J Cell Mol Med; 2020 Sep; 24(18):10744-10755. PubMed ID: 32725966
[TBL] [Abstract][Full Text] [Related]
8. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
9. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo.
Zhang K; Li Y; Liu W; Gao X; Zhang K
Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812
[TBL] [Abstract][Full Text] [Related]
10. Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway.
Ma X; Guo P; Qiu Y; Mu K; Zhu L; Zhao W; Li T; Han L
Oncotarget; 2016 Jun; 7(24):36185-36197. PubMed ID: 27167192
[TBL] [Abstract][Full Text] [Related]
11. [DDX10 promotes AIM2-inflammasome activation by maintaining AIM2 protein stability].
Zhao S; Lin M; Zhang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Apr; 36(4):289-296. PubMed ID: 32519665
[TBL] [Abstract][Full Text] [Related]
12. Cytokine secretion and pyroptosis of cholesteatoma keratinocytes mediated by AIM2 inflammasomes in response to cytoplasmic DNA.
Zhang C; Chen M; Chi Z
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760111
[TBL] [Abstract][Full Text] [Related]
13. RAD52 motif‑containing protein 1 promotes non‑small cell lung cancer cell proliferation and survival via cell cycle regulation.
Xu G; Du J; Wang F; Zhang F; Hu R; Sun D; Shen J
Oncol Rep; 2018 Aug; 40(2):833-840. PubMed ID: 29845285
[TBL] [Abstract][Full Text] [Related]
14. AIM2 Inflammasome Is Critical for Influenza-Induced Lung Injury and Mortality.
Zhang H; Luo J; Alcorn JF; Chen K; Fan S; Pilewski J; Liu A; Chen W; Kolls JK; Wang J
J Immunol; 2017 Jun; 198(11):4383-4393. PubMed ID: 28424239
[TBL] [Abstract][Full Text] [Related]
15. Human cytomegalovirus triggers the assembly of AIM2 inflammasome in THP-1-derived macrophages.
Huang Y; Liu L; Ma D; Liao Y; Lu Y; Huang H; Qin W; Liu X; Fang F
J Med Virol; 2017 Dec; 89(12):2188-2195. PubMed ID: 28480966
[TBL] [Abstract][Full Text] [Related]
16. Absent in melanoma 2 regulates tumor cell proliferation in glioblastoma multiforme.
Chen PA; Shrivastava G; Balcom EF; McKenzie BA; Fernandes J; Branton WG; Wheatley BM; Petruk K; van Landeghem FKH; Power C
J Neurooncol; 2019 Sep; 144(2):265-273. PubMed ID: 31280432
[TBL] [Abstract][Full Text] [Related]
17. C5a induces A549 cell proliferation of non-small cell lung cancer via GDF15 gene activation mediated by GCN5-dependent KLF5 acetylation.
Zhao C; Li Y; Qiu W; He F; Zhang W; Zhao D; Zhang Z; Zhang E; Ma P; Liu Y; Ma L; Yang F; Wang Y; Shu Y
Oncogene; 2018 Aug; 37(35):4821-4837. PubMed ID: 29773900
[TBL] [Abstract][Full Text] [Related]
18. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
[TBL] [Abstract][Full Text] [Related]
19. H1/pAIM2 nanoparticles exert anti-tumour effects that is associated with the inflammasome activation in renal carcinoma.
Chai D; Liu N; Li H; Wang G; Song J; Fang L; Lu Z; Yao H; Zheng J
J Cell Mol Med; 2018 Nov; 22(11):5670-5681. PubMed ID: 30160343
[TBL] [Abstract][Full Text] [Related]
20. AIM2 Engages Active but Unprocessed Caspase-1 to Induce Noncanonical Activation of the NLRP3 Inflammasome.
Cunha LD; Silva ALN; Ribeiro JM; Mascarenhas DPA; Quirino GFS; Santos LL; Flavell RA; Zamboni DS
Cell Rep; 2017 Jul; 20(4):794-805. PubMed ID: 28746866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
